[EN] LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS OLIGOMÈRES MODIFIÉS PAR LIAISON ET LEURS UTILISATIONS
申请人:IONIS PHARMACEUTICALS INC
公开号:WO2021030778A1
公开(公告)日:2021-02-18
The present disclosure provides oligomeric compounds (including oligomeric compounds that are antisense agents or portions thereof) comprising a modified oligonucleotide having at least one modified intemucleoside linking group.